FundedIQ
Artificial Intelligence

Novellia

Novellia is a patient data and healthcare technology company that develops a platform for collecting, organizing, and unifying personal medical information across multiple healthcare providers. The company provides a digital system that consolidates medical records, lab results, prescriptions, and treatment history into a single user-accessible profile. Its platform allows individuals to upload records manually and connect external patient portals, creating a centralized view of longitudinal health data. The company builds tools designed to help users track symptoms, medications, and health events over time, enabling a structured view of personal health journeys. It also supports data organization features that help users prepare for medical appointments by keeping relevant information in one place. The platform is designed to reduce fragmentation in healthcare information spread across hospitals, clinics, and diagnostic centers. Novellia also operates a data infrastructure layer that aggregates patient-permissioned health records for research purposes. This system enables the transformation of de-identified and aggregated data into insights used in medical research and treatment development. The company collaborates with healthcare and life sciences organizations to support real-world evidence generation and clinical research initiatives.

novellia.com New York, United States 1-10 employees
Total raised
$18.0M
Rounds
1
Latest
Series A
Jun 2026

Novellia is a patient data and healthcare technology company that develops a platform for collecting, organizing, and unifying personal medical information across multiple healthcare providers. The company provides a digital system that consolidates medical records, lab results, prescriptions, and treatment history into a single user-accessible profile. Its platform allows individuals to upload records manually and connect external patient portals, creating a centralized view of longitudinal health data. The company builds tools designed to help users track symptoms, medications, and health events over time, enabling a structured view of personal health journeys. It also supports data organization features that help users prepare for medical appointments by keeping relevant information in one place. The platform is designed to reduce fragmentation in healthcare information spread across hospitals, clinics, and diagnostic centers. Novellia also operates a data infrastructure layer that aggregates patient-permissioned health records for research purposes. This system enables the transformation of de-identified and aggregated data into insights used in medical research and treatment development. The company collaborates with healthcare and life sciences organizations to support real-world evidence generation and clinical research initiatives.

Novellia has raised $18.0M across 1 round. Its most recent round was a Series A of $18.0M in Jun 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Jun 2, 2026
Series A
$18.0M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Novellia is featured in

Similar companies

Xellar Biosystems

Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Series A $29.5M
Taxwire

Global Sales Tax Compliance Software

Series A $25.0M
Derya

Derya is an AI-native freight-forwarding/logistics software company that provides an AI workbench for freight forwarders and related content.

Seed $1.1M
TIFIN

TIFIN is a platform that conceives, creates, and operates fintech companies in the areas of wealth management, investments, and personal finance. Their operating companies are shaping the future of investor experience with intelligent products that recognize the uniqueness of each investor. TIFIN leverages the combined power of investment intelligence, data science, and technology to make investing a more powerful driver of financial well-being.

Series Unknown
Proception
Seed $11.0M
8090 Solutions

8090 Solutions provides an AI-native software development platform through Software Factory, a system designed to help teams manage the software development lifecycle from planning to deployment. The platform connects business requirements, architecture planning, implementation tasks, testing, and feedback within a shared workspace using AI-driven workflows and knowledge management. 8090 Solutions enables organizations to coordinate product, engineering, and business teams while maintaining visibility across software projects. The company’s solutions support custom software development, AI-assisted engineering processes, and enterprise software delivery through structured collaboration between teams and AI agents.

Series A $135M
Baz

Developers no longer have to manually piece together the impact of pull requests; Baz models, analyzes and reviews code changes, detecting breaking changes, enforcing consistency, and highlighting misaligned coding patterns. Baz makes every review faster, more accurate, and aligned with the real-world impact of the code changes being made.

Seed $9.0M
Eccentric Machines

Eccentric Machines is a manufacturer of robotic actuator technology enabling advanced motion control for embodied AI systems.

Seed $5.0M
EIS Automation

EIS Automation provides modular automation and robotic solutions for manufacturing.

Series Unknown $2.0M
Pocket

Pocket is a technology company that develops an AI-enabled note-taking system combining a dedicated recording device with companion software. Its platform records in-person conversations and phone calls, transcribes audio, and organizes the content into searchable transcripts, summaries, action items, and mind maps. The system supports offline recording, cloud synchronization, and access across mobile, desktop, and web applications, with support for more than 120 languages. Pocket also provides AI-powered features for organizing, searching, and exporting recorded information while offering integrations with task management workflows. Its products are designed for individuals and teams who need to capture, organize, and retrieve information from conversations and spoken ideas.

Seed $11.0M
Straiker

Straiker builds AI-native security solutions tp protect customers from a spectrum of security & safety risks.

Series A $64.0M
Engine Biosciences

Engine Biosciences is a biotech company that uses machine learning to study genomics for the purpose of drug discovery. They are a technology company based in both San Francisco and Asia that is funded by investors. They specialize in network biomedicine and have developed their own patented technologies that involve extensive laboratory experimentation and artificial intelligence algorithms. These technologies are used for both drug discovery and cellular reprogramming. The company's research and development platform, which was created by a team of esteemed scientists and professors from universities such as MIT and Harvard, significantly speeds up and reduces the cost of developing new medical treatments. Engine Biosciences actively utilizes this platform internally and collaborates with partners in various disease areas.

Series Unknown
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.